ELECTUS HEALTHCARE (CEDARHURST) LTD |
Registered Number:NI674703 |
For the year ended 31 December 2023
Northern Ireland
Audited Financial Statements
For the year ended 31 December 2023
ELECTUS HEALTHCARE (CEDARHURST) LTD
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
ELECTUS HEALTHCARE (CEDARHURST) LTD
Statement of Financial Position
2022
2023
Property, plant and equipment |
98,996
103,496
2
98,996
103,496
2,908
3,810
3
Trade and other receivables |
101,827
266,112
4
769,400
Cash and cash equivalents |
952,906
1,222,828
874,135
Trade and other payables: amounts falling due within one |
year |
(804,908)
(1,027,809)
5
69,227
195,019
Net current assets
Total assets less current liabilities |
294,015
172,723
294,015
Net assets
172,723
1
1
294,014
172,722
294,015
172,723
Shareholders' funds
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
These financial statements were approved and authorised for issue by the Board on 02 August 2024 and were signed by: |
The notes form part of these financial statements |
1 of 4
For the year ended 31 December 2023
ELECTUS HEALTHCARE (CEDARHURST) LTD
Notes to the Financial Statements
Statutory Information
ELECTUS HEALTHCARE (CEDARHURST) LTD is a private limited company, limited by shares, domiciled in Northern |
Ireland, registration number NI674703. |
38a Mallusk Road
Newtownabbey
Belfast
BT36 4PP
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the |
Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
modified by the revaluation of certain assets. |
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Leasehold Property
Inventories
Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
2 of 4
For the year ended 31 December 2023
ELECTUS HEALTHCARE (CEDARHURST) LTD
Notes to the Financial Statements Continued
2. Property, plant and equipment |
112,496
112,496
Provision for depreciation and impairment |
9,000
Charge for year
4,500
13,500
98,996
103,496
2022
2023
3,810
2,908
4. Trade and other receivables |
2022
2023
59,507
27,005
206,605
74,822
101,827
266,112
5. Trade and other payables: amounts falling due within one year |
2022
2023
64,301
120,988
Taxation and social security |
80,345
90,406
883,163
593,514
1,027,809
804,908
3 of 4
For the year ended 31 December 2023
ELECTUS HEALTHCARE (CEDARHURST) LTD
Notes to the Financial Statements Continued
6. Average number of persons employed |
During the year the average number of employees was 73 (2022 : 82)
7. Parent-subsidiary relationship |
7.1 The ultimate parent undertaking is EJC Propco 1A Ltd. The ultimate controlling party is Mr Edmund Coyle by virtue of his shareholding in the parent company. |
8. Disclosure under section 444(5B) of the Companies Act 2006 |
The Report of the Independent Auditor is unqualified. |
Mr Noel Hugh Conn (Senior Statutory Auditor) |
Noel Conn and Company
4 of 4